Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2013 18:59 ET | Source: SIGA Technologies Inc.

SIGA Delivers First Courses of Arestvyr(TM) Under BARDA Contract

NEW YORK, March 12, 2013 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons,...
March 06, 2013 16:00 ET | Source: SIGA Technologies Inc.

SIGA Technologies Reports Financial Results for the Fourth Quarter and Year Ended 2012

NEW YORK, March 6, 2013 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons,...
March 01, 2013 08:00 ET | Source: SIGA Technologies Inc.

SIGA to Host Fourth Quarter and Year End Business Update Call on March 6, 2013

NEW YORK, March 1, 2013 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight lethal disease causing pathogens,...
November 29, 2012 17:12 ET | Source: SIGA Technologies Inc.

ST-246(R) to be Branded Arestvyr(TM)

NEW YORK, Nov. 29, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons,...
November 05, 2012 16:00 ET | Source: SIGA Technologies Inc.

SIGA Technologies Reports Financial Results for the Third Quarter of 2012

NEW YORK, Nov. 5, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons,...
October 29, 2012 17:30 ET | Source: SIGA Technologies Inc.

SIGA to Host Third Quarter Business Update Call on November 5, 2012

NEW YORK, Oct. 29, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight lethal disease causing pathogens,...
August 06, 2012 16:00 ET | Source: SIGA Technologies Inc.

SIGA Technologies Reports Financial Results for the Second Quarter of 2012

NEW YORK, Aug. 6, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons,...
July 30, 2012 16:00 ET | Source: SIGA Technologies Inc.

SIGA to Host Second Quarter Business Update Call on August 6, 2012

NEW YORK, July 30, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight lethal disease causing pathogens,...
June 04, 2012 16:00 ET | Source: SIGA Technologies Inc.

SIGA Appoints William J. Haynes as General Counsel

NEW YORK, June 4, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons,...
June 01, 2012 10:23 ET | Source: SIGA Technologies Inc.

Chancery Court Issues Final Judgment in Litigation Brought by PharmAthene

NEW YORK, June 1, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons,...